Testicular Yolk Sac TumorSymptoms, Doctors, Treatments, Advances & More
Testicular Yolk Sac Tumor Overview
Learn About Testicular Yolk Sac Tumor
UCI Health Chao Family Comprehensive Cancer Center
Mihaela Cristea is a Hematologist and an Oncologist practicing medicine in Orange, California. Dr. Cristea is rated as a Distinguished provider by MediFind in the treatment of Testicular Yolk Sac Tumor. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Lung Cancer, Virilizing Ovarian Tumor, and Endoscopy.
Duke Cancer Center Gynecology Clinic
Andrew Berchuck is a Gynecologic Oncologist practicing medicine in Durham, North Carolina. Dr. Berchuck is rated as a Distinguished provider by MediFind in the treatment of Testicular Yolk Sac Tumor. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Oophorectomy, and Tubal Ligation. Dr. Berchuck is board certified in American Board Of Obstetrics/Gynecology, Obstetrics & Gynecology and American Board Of Obstetrics/Gynecology, Gynecologic Oncology. Dr. Berchuck is currently accepting new patients.
Prisma Health Cancer Institute – Faris Rd.
Larry Puls is an Oncologist practicing medicine in Greenville, South Carolina. Dr. Puls is rated as a Distinguished provider by MediFind in the treatment of Testicular Yolk Sac Tumor. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Vulvar Cancer, Malignant Mixed Mullerian Tumor, Ovarian Cancer, Hernia Surgery, and Salpingo-Oophorectomy. Dr. Puls is board certified in American Board Of Obstetrics And Gynecology. Dr. Puls is currently accepting new patients.
Summary: The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary antitumor activity of BGB-B2033 alone or in combination with tislelizumab, with or without bevacizumab, in adults with advanced or metastatic hepatocellular carcinoma (HCC), alpha-fetoprotein (AFP)-producing gastric cancer (GC), extragonadal yolk sac tumors, non-dysgermi...
Summary: This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of t...


